JNC 8 Guidelines for Managing Hypertension
The JNC 8 guidelines recommend a blood pressure goal of <140/90 mmHg for the general population under age 60 and <150/90 mmHg for those aged 60 and older, with initial pharmacological treatment options including thiazide diuretics, calcium channel blockers (CCBs), ACE inhibitors, or angiotensin receptor blockers (ARBs). 1
Blood Pressure Thresholds and Treatment Goals
- For the general population aged 60 years and older: Goal BP <150/90 mmHg 1
- For the general population under age 60: Goal BP <140/90 mmHg 1
- For patients with diabetes (all ages): Goal BP <140/90 mmHg (revised from previous JNC 7 goal of <130/80 mmHg) 1
- For patients with chronic kidney disease (all ages): Goal BP <140/90 mmHg (revised from previous JNC 7 goal of <130/80 mmHg) 1
First-Line Pharmacological Treatment Recommendations
- For the general non-black population: Initial therapy can include thiazide-type diuretics, calcium channel blockers (CCBs), ACE inhibitors, or ARBs 1
- For the black population: Initial therapy should be a thiazide-type diuretic or CCB 1
- For patients with chronic kidney disease: Include an ACE inhibitor or ARB in the treatment regimen, regardless of race 1
- For patients with diabetes: Initial therapy can include thiazide-type diuretics, CCBs, ACE inhibitors, or ARBs 1
Key Algorithm for Treatment Approach
- Start with one of the recommended first-line medications at an appropriate dose 1
- If blood pressure goal is not reached within one month, either:
- Increase the dose of the initial medication, or
- Add a second medication from the recommended first-line classes 1
- If blood pressure goal is still not reached with two medications, add a third medication from the recommended first-line classes 1
- If blood pressure goal cannot be reached using the recommended first-line medications, or if there are adverse effects, other antihypertensive drugs may be used 1
Important Differences from Previous Guidelines
- JNC 8 focuses on evidence from randomized controlled trials, unlike previous guidelines that incorporated expert opinion 2
- Beta-blockers are no longer recommended as first-line therapy for the general population 1
- Combined use of ACE inhibitors and ARBs is not recommended due to increased risk of adverse events 1
- Treatment thresholds and goals are now the same to avoid confusion 1
- If pharmacological treatment results in BP below the recommended target without adverse effects, treatment should be continued rather than reduced 1
Lifestyle Modifications
JNC 8 supports the recommendations of the 2013 Lifestyle Work Group for all patients with hypertension 1:
- Regular aerobic physical activity: 30-60 minutes of moderate-intensity dynamic exercise 4-7 days per week 1
- Weight reduction: Target BMI 18.5-24.9 kg/m² and waist circumference <102 cm for men and <88 cm for women 1
- Dietary recommendations: Diet rich in fruits, vegetables, low-fat dairy products, dietary and soluble fiber, whole grains, and plant proteins; reduced in saturated fat and cholesterol 1
- Sodium reduction: Limit to <2,400 mg sodium per day; further reduction to 1,500 mg/day is desirable 1
- Alcohol limitation: No more than 2 drinks per day for men and 1 drink per day for women 1
- Smoking cessation 1
Common Pitfalls and Caveats
- Do not discontinue medications just because a patient's BP is below target if there are no adverse effects 1
- Avoid combined use of ACE inhibitors and ARBs due to increased risk of hyperkalemia and acute kidney injury 1, 3
- Accurate BP measurement is crucial - ensure proper technique with patient seated, feet on floor, arm supported, and appropriate cuff size 1
- Consider ambulatory blood pressure monitoring (ABPM) or home blood pressure monitoring (HBPM) for borderline cases or suspected white-coat hypertension 1
- For patients with multiple comorbidities, the guidelines should be considered minimal standards rather than rigid rules 1
- If BP is >20/10 mmHg above goal, consider initiating therapy with two agents, one of which should typically be a thiazide-type diuretic 4
Special Populations
- Elderly patients (>80 years): Consider frailty and comorbidities; treatment goals may need to be individualized with clinical discretion 1
- Black patients: Thiazide diuretics and CCBs are more effective as initial therapy than ACE inhibitors 1, 5
- Patients with diabetes and CKD: ACE inhibitors or ARBs should be part of the treatment regimen, particularly if proteinuria is present 1
The JNC 8 guidelines represent a significant shift toward evidence-based recommendations that simplify hypertension management while maintaining focus on reducing morbidity and mortality through effective blood pressure control.